论文部分内容阅读
病例选择:症状开始时间明确并于24小时内入院。随机分为二组,AMI+HT组:符合WHO的AMI诊断标准,病前有明确记载高血压病史,入院后无论血压高低均归于此组。AMI组:符合WHO的AMI诊断标准,入院后血压正常。所有患者肝功、电解质检查均正常,2周内均无外伤史、电击除颤等病史。 血清酶标本采集与测定,发病后24、48、72小时分别采静脉血测定CoT、CK、LDH。使用日本产7150全自动生化分析仪,采用血清心肌酶连续酶标测定法进行检测。 统计学处理:所有计量资料均以X±SX表示,用t检验进行显著性差异比较。 结果:AMI+HT和AMI二组发病年龄以45～80岁为高峰,男女比例为(36:20),二组中性别、年龄和发病距入院时间均无显著差异(P>0.05)。 二组GoT、CK、LDH峰值的改变均无显著差异。
Case Selection: The onset of symptoms was clear and admitted within 24 hours. Randomly divided into two groups, AMI + HT group: in line with the WHO AMI diagnostic criteria, a clear history of hypertension recorded before the disease, regardless of the level of blood pressure after admission were attributed to this group. AMI group: in line with the WHO AMI diagnostic criteria, normal blood pressure after admission. Liver function in all patients, electrolyte tests were normal, no history of trauma within 2 weeks, electric shock defibrillation and other medical history. Serum enzyme samples were collected and measured 24,88 and 72 hours after the onset of venous blood were collected to detect CoT, CK, LDH. The use of Japan-made 7150 automatic biochemical analyzer, the use of serum myocardial enzyme continuous enzyme assay for detection. Statistical analysis: All measurement data are expressed as X ± SX, t-test for significant differences in comparison. Results: The onset age of AMI + HT and AMI groups were 45 to 80 years old. The ratio of male to female was (36:20). There was no significant difference in gender, age and incidence of hospitalization between the two groups (P> 0.05). There was no significant difference in peak change of GoT, CK and LDH between the two groups.